http://www.itftennis.com/news/231175.aspx
Decision in the case of Maria Sharapova
8 June 2016 – London, ENGLAND - An Independent Tribunal appointed under
Article 8.1 of the 2016 Tennis Anti-Doping Programme (the "Programme") has
found that Maria Sharapova committed an Anti-Doping Rule Violation under
Article 2.1 of the Programme and as a consequence has disqualified the
affected results and imposed a period of ineligibility of two years,
commencing on 26 January 2016.
Ms. Sharapova, a 29-year-old player from Russia, provided a urine sample on
26 January 2016, after her quarter-final match at the 2016 Australian Open in
Melbourne, Australia. That sample was sent to the WADA-accredited laboratory
in Montreal, Canada for analysis, and was found to contain meldonium, which
is a metabolic modulator that is included under section S4 (Hormone and
Metabolic Modulators) of the 2016 WADA Prohibited List, and therefore is also
prohibited under the Programme.
On 2 March 2016, Ms. Sharapova was charged with an Anti-Doping Rule Violation
under Article 2.1 of the Programme (presence of a Prohibited Substance in a
Player’s Sample). She promptly admitted that she had committed the
Anti-Doping Rule Violation charged, and asked for a hearing before an
Independent Tribunal in accordance with Article 8 of the Programme to
determine the consequences to be imposed on her for that violation.
At a two-day hearing on 18-19 May 2016, the Independent Tribunal received
evidence and heard legal arguments from both parties, and subsequently issued
a reasoned decision on 8 June, which is available below. The Independent
Tribunal determined that (1) Ms. Sharapova should serve a period of
ineligibility of two years; (2) due to her prompt admission of her violation,
that period of ineligibility should be back-dated under Article 10.10.3(b) of
the Programme to commence from 26 January 2016 (the date of sample
collection) and so should end at midnight on 25 January 2018; and (3) her
results at the 2016 Australian Open should be disqualified, with resulting
forfeiture of the ranking points and prize money that she won at that event.
The Tennis Anti-Doping Programme applies to all players competing at Grand
Slam tournaments and events sanctioned by the ITF, ATP, and WTA. Players are
tested for substances prohibited by the World Anti-Doping Agency and, upon a
finding that an Anti-Doping Rule Violation has been committed, sanctions are
imposed under the Programme in compliance with the requirements of the World
Anti-Doping Code. More information on the Programme, sanctions, statistics,
and related matters can be found at www.itftennis.com/antidoping.
禁賽兩年，到2018/01/25
2016澳網資格取消，積分獎金收回